ARTES Biotechnology announce expansion of the management board
ARTES Biotechnology GmbH announced today that Volker Jenzelewski reinforces the executive board of ARTES as Managing Dir…
ARTES Biotechnology GmbH announced today that Volker Jenzelewski reinforces the executive board of ARTES as Managing Dir…
company focusing on niche pharmaceutical products, are proud to announce a strategic collaboration aimed at advancing ph…
In 2002 at May 10th Michael Piontek founded ARTES as a one-man operation executing and taking care of two license deals…
ARTES Biotechnology and Burnet Institute recently published data on the efficient production of malaria vaccine candidat…
Under the titel: “ERA-Net EuroTransBio-8: PLURIVAX, development of a virus-like-particle (VLP) based vaccine platform an…
The French R&D tax credit CIR gives French companies the ability to claim tax relief on 30% on all generated costs outso…
ARTES Biotechnology and Burnet Institute announce they have joined forces to develop a novel, effective vaccine to preve…
ARTES Biotechnology, specialized in recombinant protein production, process and vaccine development from microbial expre…
B3C newswire / -[/b] ARTES Biotechnology, InstrAction and Q-Biologicals establish a three-party consortium for vaccine d…
Die Biologische Station der Universität Greifswald auf der Insel Hiddensee öffnet am 2. Juli 2014 ihre Türen für Neugier…